Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos One|November 15, 2019
Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancerViktor Sandblom, Johan Spetz, Emman Shubbar, et al.
Plos One|May 28, 2020
Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitorsViktor Sandblom, Johan Spetz, Emman Shubbar, et al.
BMC Cancer|August 26, 2021
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotateArman Romiani, Johan Spetz, Emman Shubbar, et al.
Plos One|December 31, 2020
Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose 131I exposureMalin Larsson, Nils Rudqvist, Johan Spetz, et al.
Radiation Protection Dosimetry|August 28, 2025
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotideNishte Rassol, Charlotte Ytterbrink, Daniella Pettersson, et al.
Plos One|October 27, 2021
Correction: Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose 131I exposureMalin Larsson, Nils Rudqvist, Johan Spetz, et al.
Radiation Protection Dosimetry|August 28, 2025
Early proteomic response in thyroid gland after 131I administration in female Balb/c miceNils Rudqvist, Johan Spetz, Emil Schüler, et al.
Nuclear Medicine and Biology|March 5, 2018
Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapyJohan Spetz, Nils Rudqvist, Britta Langen, et al.
EJNMMI Research|March 22, 2019
Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude miceJohan Spetz, Britta Langen, Nils-Petter Rudqvist, et al.
EJNMMI Research|January 19, 2017
Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1Johanna Dalmo, Johan Spetz, Mikael Montelius, et al.
Pageof 4